Physician Practice

The Doctor’s Office

Physician Practice Perspective, December 21, 2002

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Physician Practice Perspective.

December 2002 No. 246 Guidelines for the pharmaceutical industry can affect youThe Office of Inspector General (OIG) kicked off October with the release of the Compliance Program Guidance for Pharmaceutical Manufacturers. While the notice focuses on the marketing practices of the pharmaceutical industry, office managers should also take heed-especially when it comes to anti-kickback laws. The guidance focuses on three primary risk areas:• Reporting of drug prices for government reimbursement • Offering kickbacks and other illegal remuneration• Pr

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Physician Practice Perspective.

Most Popular